|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siani LM and Pulica C: Stage I–IIIC right
colonic cancer treated with complete mesocolic excision and central
vascular ligation: Quality of surgical specimen and long term
oncologic outcome according to the plane of surgery. Minerva Chir.
69:199–208. 2014.PubMed/NCBI
|
|
3
|
De Rosa M, Rega D, Costabile V, Duraturo
F, Niglio A, Izzo P, Pace U and Delrio P: The biological complexity
of colorectal cancer: Insights into biomarkers for early detection
and personalized care. Therap Adv Gastroenterol. 6:861–886. 2016.
View Article : Google Scholar
|
|
4
|
Schmoll HJ, Van Cutsem E, Stein A,
Valentini V, Glimelius B, Haustermans K, Nordlinger B, Van de Velde
CJ, Balmana J, Regula J, et al: ESMO consensus guidelines for
management of patients with colon and rectal cancer. A personalized
approach to clinical decision making. Ann Oncol. 23:2479–2516.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tveit K, Guren T, Glimelius B, Pfeiffer P,
Sorbye H, Pyrhonen S, Kure E, Ikdahl T, Skovlund E, Fokstuen T, et
al: Phase III trial of cetuximab with continuous or intermittent
fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX
alone in first-line treatment of metastatic colorectal cancer: The
NORDIC-VII study. J Clin Oncol. 30:1755–1762. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Peeters M, Price T, Cervantes A, Sobrero
A, Ducreux M, Hotko Y, André T, Chan E, Lordick F, Punt CJ, et al:
Randomized phase III study of panitumumab with fluorouracil,
leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as
second-line treatment in patients with metastatic colorectal
cancer. J Clin Oncol. 28:4706–4713. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Van Cutsem E, Köhne C, Hitre E, Zaluski J,
Chang Chien C, Makhson A, D'Haens G, Pintér T, Lim R, Bodoky G, et
al: Cetuximab and chemotherapy as initial treatment for metastatic
colorectal cancer. N Engl J Med. 360:1408–1417. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Martenson JA Jr, Willett CG, Sargent DJ,
Mailliard JA, Donohue JH, Gunderson LL, Thomas CR Jr, Fisher B,
Benson AB III, Myerson R and Goldberg RM: Phase III study of
adjuvant chemotherapy and radiation therapy compared with
chemotherapy alone in the surgical adjuvant treatment of colon
cancer: Results of intergroup protocol 0130. J Clin Oncol.
22:3277–3283. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ma B, Gao P, Wang H, Xu Q, Song Y, Huanget
X, Sun J, Zhao J, Luo J, Sun Y and Wang Z: What has preoperative
radio(chemo)therapy brought to localized rectal cancer patients in
terms of perioperative and long-term outcomes over the past
decades? A systematic review and meta-analysis based on 41,121
patients. Int J Cancer. 141:1052–1065. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang Y and Weinberg RA:
Epithelial-to-mesenchymal transition in cancer: Complexity and
opportunities. Front Med. 12:361–373. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jope RS: Lithium and GSK-3: One inhibitor,
two inhibitory actions, multiple outcomes. Trends Pharmacol Sci.
24:441–443. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Post RM: The new news about lithium: An
underutilized treatment in the United States.
Neuropsychopharmacology. 43:1174–1179. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Forlenza OV, De-Paula VJ and Diniz BS:
Neuroprotective effects of lithium: Implications for the treatment
of Alzheimer's disease and related neurodegenerative disorders. ACS
Chem Neurosci. 5:443–450. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Medić B, Stojanović M, Štimec B, Divac N,
Vujović KS, Stojanović R, Čolović M, Krstić DZ and Prostran M:
Lithium-pharmacological and toxicological aspects: The current
state of the art. Curr Med Chem. Sep 4–2018.(Epub ahead of print).
View Article : Google Scholar
|
|
15
|
Costabile V, Duraturo F, Delrio P, Rega D,
Pace U, Liccardo R, Rossi GB, Genesio R, Nitsch L, Izzo P and De
Rosa M: Lithium chloride induces mesenchymal-to-epithelial
reverting transition in primary colon cancer cell cultures. Int J
Oncol. 46:1913–1923. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Turano M, Costabile V, Cerasuolo A,
Duraturo F, Liccardo R, Delrio P, Pace U, Rega D, Dodaro CA, Milone
M, et al: Characterisation of mesenchymal colon tumour-derived
cells in tumourspheres as a model for colorectal cancer
progression. Int J Oncol. 53:2379–2396. 2018.PubMed/NCBI
|
|
17
|
Rinaldo C, Moncada A, Gradi A, Ciuffini L,
D'Eliseo D, Siepi F, Prodosmo A, Giorgi A, Pierantoni GM, Trapasso
F, et al: HIPK2 controls cytokinesis and prevents tetraploidization
by phosphorylating histone H2B at the midbody. Mol Cell. 47:87–98.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Galatola M, Paparo L, Duraturo F, Turano
M, Rossi GB, Izzo P and De Rosa M: Beta catenin and cytokine
pathway dysregulation in patients with manifestations of the ‘PTEN
hamartoma tumor syndrome’. BMC Med Genet. 13:282012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Valentino T, Palmieri D, Vitiello M,
Pierantoni GM, Fusco A and Fedele M: PATZ1 interacts with p53 and
regulates expression of p53-target genes enhancing apoptosis or
cell survival based on the cellular context. Cell Death Dis.
4:e9632013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Di Maio N, Vicidomini R, Angrisani A,
Belli V, Furia M and Turano M: A new role for human dyskerin in
vesicular trafficking. FEBS Open Bio. 7:1453–1468. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ong BA, Vega KJ and Houchen CW: Intestinal
stem cells and the colorectal cancer microenvironment. World J
Gastroenterol. 20:1898–1909. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vichalkovski A, Gresko E, Hess D,
Restuccia DF and Hemmings BA: PKB/AKT phosphorylation of the
transcription factor Twist-1 at Ser42 inhibits p53 activity in
response to DNA damage. Oncogene. 29:3554–3565. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang Y, Pan X, Lei W, Wang J and Song J:
Transforming growth factor-beta1 induces epithelial-to-mesenchymal
transition and apoptosis via a cell cycle-dependent mechanism.
Oncogene. 25:7235–7244. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vega S, Morales AV, Ocaña OH, Valdés F,
Fabregat I and Nieto MA: Snail blocks the cell cycle and confers
resistance to cell death. Genes Dev. 18:1131–1143. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sharma A, Boise LH and Shanmugam M: Cancer
metabolism and the evasion of apoptotic cell death. Cancers
(Basel). 11(pii): E11442019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hassan M, Watari H, AbuAlmaaty A, Ohba Y
and Sakuragi N: Apoptosis and molecular targeting therapy in
cancer. Biomed Res Int. 2014:1508452014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Aubrey BJ, Kelly GL, Janic A, Herold MJ
and Strasser A: How does p53 induce apoptosis and how does this
relate to p53-mediated tumour suppression? Cell Death Differ.
25:104–113. 2018. View Article : Google Scholar
|
|
28
|
Chauhan D, Hideshima T, Rosen S, Reed JC,
Kharbanda S and Anderson KC: Apaf-1/cytochrome c-independent and
Smac-dependent induction of apoptosis in multiple myeloma (MM)
cells. J Biol Chem. 276:24453–24456. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kroemer G and Reed JC: Mitochondrial
control of cell death. Nat Med. 6:513–519. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ryan KM, Ernst MK, Rice NR and Vousden KH:
Role of NF-kappaB in p53-mediated programmed cell death. Nature.
404:892–897. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ionov Y, Yamamoto H, Krajewski S, Reed JC
and Perucho M: Mutational inactivation of the proapoptotic gene BAX
confers selective advantage during tumor clonal evolution. Proc
Natl Acad Sci USA. 97:10872–10877. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Miyashita T, Krajewski S, Krajewska M,
Wang HG, Lin HK, Liebermann DA, Hoffman B and Reed JC: Tumor
suppressor p53 is a regulator of bcl-2 and bax gene expression in
vitro and in vivo. Oncogene. 9:1799–1805. 1994.PubMed/NCBI
|
|
33
|
Vaux DL: Immunopathology of
apoptosis-introduction and overview. Springer Semin Immunopathol.
19:271–278. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Frischand SM and Screaton RA: Anoikis
mechanisms. Curr Opinin Cell Biol. 13:555–562. 2001. View Article : Google Scholar
|
|
35
|
Mita AC, Mita MM, Nawrocki ST and Giles
FJ: Survivin: Key regulator of mitosis and apoptosis and novel
target for cancer therapeutics. Clin Cancer Res. 14:5000–5005.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pawlik TM and Keyomarsi K: Role of cell
cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol
Biol Phys. 59:928–942. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Pfeifer D, Wallin A, Holmlund B and Sun
XF: Protein expression following gamma-irradiation relevant to
growth arrest and apoptosis in colon cancer cells. J Cancer Res
Clin Oncol. 135:1583–1592. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang J, Yang L, Yang J, Kuropatwinski K,
Wang W, Liu XQ, Hauser J and Brattain MG: Transforming growth
factor beta induces apoptosis through repressing the
phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer
cells. Cancer Res. 68:3152–3160. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Rouhani M, Goliaei B, Khodagholi F and
Nikoofar A: Lithium increases radiosensitivity by abrogating DNA
repair in breast cancer spheroid culture. Arch Iran Med.
17:352–360. 2014.PubMed/NCBI
|
|
40
|
Du C, Jaggi M, Zhang C and Balaji KC:
Protein kinase D1-mediated phosphorylation and subcellular
localization of beta-catenin. Cancer Res. 69:1117–1124. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Fodde R and Brabletz T: Wnt/beta-catenin
signaling in cancer stemness and malignant behavior. Curr Opin Cell
Biol. 19:150–158. 2007. View Article : Google Scholar : PubMed/NCBI
|
